This bill directs the Small Business Administration to create educational resources for small business owners and employees regarding their rights and responsibilities during immigration enforcement actions. The SBA must develop online modules, a physical card, and planning guides that explain how to respond to searches or arrests, including the constitutional right to remain silent and consult a lawyer. These materials will be made available in English and the 15 most commonly spoken languages in the U.S., with content reviewed by legal experts and government agencies to ensure accuracy.
This bill establishes federal protections and funding to expand access to in vitro fertilization and intrauterine insemination for individuals, military service members, and veterans. It requires most private health plans, Medicaid programs, and Medicare to cover these fertility treatments without imposing higher cost-sharing than other medical services. Additionally, the legislation mandates that the Department of Defense and the Department of Veterans Affairs provide specific fertility preservation and treatment benefits to uniformed service members and eligible veterans. The bill also includes preemption clauses that override state laws restricting these procedures and prohibits discrimination based on marital status, sex, or sexual orientation in the provision of care.
The Federal Naming Standards Act prohibits the government from naming or renaming federal buildings, facilities, or programs after elected officials or political appointees while they are in office and for ten years after they leave. This restriction also applies indefinitely to individuals who earn more than $1 million annually from commercial use of their name or likeness, though it does not affect deceased individuals or names already established before the law takes effect. To enforce these rules, agency inspectors general must investigate complaints about violations and report their findings to agency heads and Congress within 90 days. The law allows for the incidental use of names in historical or educational contexts, provided the name is not used as the official title of a federal site or program.
This bill prohibits the United States from providing any voluntary or assessed funding to the United Nations Relief and Works Agency for Palestine Refugees in the Near East. The restriction applies directly to the U.S. government's financial contributions to the agency, effectively cutting off official U.S. support. However, the law allows for humanitarian aid to individuals who receive help from UNRWA if that aid is delivered through other organizations that do not promote violence, terrorism, or antisemitism. Ultimately, the legislation mandates a complete halt to direct U.S. funding for UNRWA while permitting indirect assistance under specific conditions.
This concurrent resolution directs the President to withdraw United States Armed Forces from any hostilities against Iran. It specifically invokes the War Powers Resolution, mandating this removal unless Congress formally declares war or provides specific authorization for military force against Iran. The bill clarifies that it does not prevent the U.S. from acting in self-defense, maintaining a defensive troop presence in the region, or continuing intelligence activities related to threats from Iran.
The Lawful Hemp Protection Act establishes a comprehensive federal regulatory framework for hemp-derived cannabinoid products to ensure safety, quality, and consumer protection. It defines specific hemp products, prohibits the sale of items containing artificially modified cannabinoids like HHC or THCP, and mandates strict labeling requirements including THC milligram counts and health warnings. The bill creates a new tax on these products, requires manufacturers and wholesalers to obtain federal permits, and enforces a three-tiered distribution system for hemp beverages to prevent market consolidation. Additionally, it allows Medicare Advantage plans to cover these products for chronically ill patients and directs funds toward impaired driving enforcement and consumer safety oversight.
This bill, known as the D.C. Taxing Authority Review Act, modifies the rules for how new taxes and fees proposed by the District of Columbia government are reviewed by Congress. It requires that any D.C. law imposing or increasing a tax or fee must receive explicit approval from a joint resolution passed by both the House of Representatives and the Senate within 60 days, or else the law will not take effect. Additionally, the bill limits the time for debating these specific approval resolutions to one hour, split evenly between supporters and opponents. These changes directly affect the District of Columbia government's ability to enact new financial measures without prior congressional consent.
The Main Street Capital Access Act reduces regulatory burdens for smaller banks, particularly those with less than $10 billion in assets. Key provisions include a 3-year phase-in period for new banks to meet capital requirements, lower leverage ratio requirements for rural banks (7.5% for the first 2 years), and a 30-day review process for business plan deviations. The bill also establishes an Office of Independent Examination Review, sets specific timelines for examinations (270 days) and reports (90 days), and creates a "least cost exception" for bank resolutions to prevent excessive concentration of the banking system. These changes aim to promote new bank formation, improve regulatory efficiency, and support community banking while maintaining financial stability.
This bill requires pharmacy benefits managers (PBMs) administering prescription drug benefits for federal employee health plans to reimburse pharmacies at specific rates, including the national average drug cost plus a small percentage or $50, whichever is lower. It prohibits PBMs from favoring their own pharmacies, restricting patient choice, or reducing pharmacy payments after claims are processed. The bill establishes $10,000 civil penalties for violations, with debarment from federal health plans after 10 penalties in 10 years. This directly affects PBMs, in-network pharmacies, and federal health benefit plans covering millions of federal employees and their families. The law aims to ensure fair reimbursement practices and maintain pharmacy choice under the Federal Employees Health Benefits Program.
This concurrent resolution formally recognizes the persistent wage gap between Black women and white, non-Hispanic men in the United States. It highlights data showing that Black women earn significantly less than their male counterparts and reaffirms Congress's support for existing laws that prohibit pay discrimination based on sex or race. The document does not create new laws or change policy but serves as a symbolic statement to raise awareness about the economic disparities faced by Black women.
The Justice for Incarcerated Moms Act aims to improve maternal health outcomes for pregnant and postpartum individuals in the criminal justice system by restricting financial incentives for states that use restraints on pregnant inmates. Under the bill, states receiving federal justice grants would face a 25 percent funding penalty if they fail to implement laws limiting the use of shackles on pregnant individuals, with those withheld funds redirected to compliant states. The legislation also directs the Bureau of Prisons and the Department of Justice to create and fund programs in at least six federal facilities and across various state and local prisons that provide specialized prenatal care, mental health support, and reentry assistance. These programs are designed to address specific health disparities, particularly for racial and ethnic minority groups, by offering culturally competent care, nutrition counseling, and opportunities to maintain contact with newborn children. Additionally, the act requires an independent oversight organization to monitor program implementation and mandates a Government Accountability Office report to analyze maternal and infant health data within the correctional system.
The Americans vs. Poisonous Pesticides Act amends federal pesticide laws to allow state courts to hear lawsuits alleging that pesticide labels fail to warn about health or environmental risks. It clarifies that a pesticide's federal registration and label approval do not automatically block these state claims, though they serve as initial evidence of compliance. The bill also permits companies to update their product labels to address new safety information without waiting for prior government approval, subject to potential review by the agency. These changes apply to both new lawsuits and cases already in progress, ensuring that federal rules do not limit existing state legal remedies for damages or injunctive relief.
